From Rs 40 to Rs 500: This multibagger Smallcap pharma stock recorded over 1000 per cent returns in just 3 years! Know its story here From Rs 40 to Rs 500: This multibagger Smallcap pharma stock recorded over 1000 per cent returns in just 3 years! Know its story here The capsule manufacturing capacity is around 18 BCPA (Billion capsules per annum), which is likely to see a significant rise to 22 BCPA via capital expansion in this fiscal year. Rohit Kale / Friday, April 21, 2023 / Article rating: 4.2 This smallcap company, belonging to the pharma domain, has exhibited strong growth phase along with improvement in financial numbers.
From Rs 55 to Rs 580: This low PE small-cap pharma stock became multibagger in just three years! From Rs 55 to Rs 580: This low PE small-cap pharma stock became multibagger in just three years! The stock has been a proven multi-bagger, having surged 10 times in the last three years. Last year, it increased shareholders’ wealth by 250 per cent! Rohit Kale / Tuesday, September 6, 2022 / Article rating: 4.0 Belonging to the pharmaceutical sector, this Rs 450 crore-market cap company works in manufacturing modernised capsule shells and pharmaceutical dosage forms. It also supplies various APIs to big pharmaceutical companies.